Less Ads, More Data, More Tools Register for FREE

Pin to quick picksJade Road Inv Regulatory News (JADE)

  • There is currently no data for JADE

Subscription Agreement

28 Apr 2025 07:00

RNS Number : 3657G
Jade Road Investments Limited
28 April 2025
 

 

JADE ROAD INVESTMENTS LIMITED

("Jade Road Investments", "JADE" or the "Company)

Subscription Agreement

 

Jade Road Investments Limited ("Jade Road" or the "Company"), an Investing Company quoted on AIM is pleased to announce that it has entered into a subscription agreement with Verus Financial Services Limited ('Verus') for £1 million through the subscription for 100,000,000 new shares priced at 1p representing 72.19% of the Company's enlarged issued share capital following the issue of shares ("Subscription").

 

The Company intends to use proceeds to make investments in line with its investing strategy.

 

The Company looks forward to updating the market on further developments and target investment pipeline in due course.

 

Verus is an independent financial adviser authorised and regulated by the Financial Conduct Authority which is ultimately owned by Mr Christopher Doran. Verus is making the Subscription on behalf of its underlying clients, none of whom will beneficially own more than 30% of the Company's enlarged share capital upon completion of the Subscription.

 

Application will be made to AIM for the admission of the 100,000,000 subscription shares which is expected to become effective and dealings to commence on or around 2 May 2025.

 

Following Admission, the total voting rights in the Company will be 138,522,365 and shareholders will be able to use this figure as the denominator by which they are required to notify their interest in, or change in interest in the Company under the Disclosure Guidance and Transparency rules.

 

For further information, please contact:

 

Jade Road Investments Limited

 

+44 (0) 778 531 5588

John Croft

 

Zeus - Nominated Adviser

 

+44 (0) 203 829 5000

James Joyce / Andrew de Andrade

 

Hybridan LLP - Broker

 

 +44 (0) 20 3764 2341

Claire Louise Noyce

 

 

This announcement contains inside information for the purposes of Article 7 of the UK version of Regulation (EU) No 596/2014 which is part of UK law by virtue of the European Union (Withdrawal) Act 2018, as amended. Upon the publication of this announcement via a Regulatory Information Service, this inside information is now considered to be in the public domain

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
AGRPKOBQFBKDDQB
Date   Source Headline
28th Jun 20245:43 pmRNSFinal Results
29th May 20247:00 amRNSCompletion of the disposal of Legacy Assets
13th May 20247:00 amRNSUpdate on the disposal of Legacy Assets
1st May 20244:28 pmRNS2023 AGM Voting Results
8th Apr 20244:23 pmRNSPosting of Circular and Notice of AGM
3rd Apr 20243:58 pmRNSUpdates on Disposal of Legacy Assets
22nd Jan 20247:00 amRNSWebsite Update: Company Presentation and Q&A
5th Jan 20247:00 amRNSInvestor Meet Company Presentation
2nd Jan 20247:00 amRNSProposed Disposal of Legacy Assets & Restructuring
13th Dec 20237:00 amRNSOperational Update
15th Nov 20237:56 amRNSInvestment in Heirloom Litigation Finance
29th Sep 20237:00 amRNSINTERIM RESULTS FOR SIX MONTHS ENDED 30 JUNE 2023
4th Sep 20237:00 amRNSPlacement of Shares
25th Aug 202311:56 amRNSPlacement of shares
26th Jul 20232:10 pmRNSSecond Supplemental Bond Instrument Update
17th Jul 202311:37 amRNSUpdate on Interest Payment to Bondholders
3rd Jul 20235:45 pmRNSBond Interest Payment Update, Proposed Fundraising
26th May 20232:06 pmRNS2022 AGM Voting Results
26th May 20231:16 pmRNSFinal Results
9th May 20237:00 amRNSCorrection: Finding a Genuine Alternative
5th May 20231:57 pmRNSFinding a Genuine Alternative
5th Apr 20237:00 amRNSNew Investment
27th Mar 20237:00 amRNSRevision to Investment Management Agreement
24th Mar 202310:56 amRNSBoard Change
13th Mar 20234:40 pmRNSSecond Price Monitoring Extn
13th Mar 20234:35 pmRNSPrice Monitoring Extension
6th Mar 20234:40 pmRNSSecond Price Monitoring Extn
6th Mar 20234:35 pmRNSPrice Monitoring Extension
21st Feb 20237:00 amRNSResults of General Meeting
20th Feb 20237:00 amRNSCompletion of Conditional Equity Fundraise
31st Jan 20233:45 pmRNSReplacement Circular
31st Jan 20238:44 amRNSCirc re. Investing Policy, Proposed Placing & GM
1st Dec 202211:19 amRNSUS Dollar-denominated Corporate Bonds
21st Oct 20227:42 amRNSUS Dollar-denominated corporate bonds
22nd Sep 202211:59 amRNSINTERIM RESULTS FOR SIX MONTHS ENDED 30 JUNE 2022
18th Aug 20224:41 pmRNSSecond Price Monitoring Extn
18th Aug 20224:35 pmRNSPrice Monitoring Extension
18th Aug 20222:28 pmRNSPartial Divestment in Meize Energy Industries
17th Aug 20229:05 amRNSSecond Price Monitoring Extn
17th Aug 20229:00 amRNSPrice Monitoring Extension
1st Aug 202211:05 amRNSSecond Price Monitoring Extn
1st Aug 202211:00 amRNSPrice Monitoring Extension
1st Aug 20229:05 amRNSSecond Price Monitoring Extn
1st Aug 20229:00 amRNSPrice Monitoring Extension
20th Jul 20228:36 amRNSPartial Divestment in Meize Energy Industries
1st Jul 202210:29 amRNSReplacement for Final Results
30th Jun 20227:00 amRNSFinal Results
22nd Jun 20227:39 amRNSPartial divestment in Meize Energy Industries
20th May 20224:41 pmRNSSecond Price Monitoring Extn
20th May 20224:36 pmRNSPrice Monitoring Extension

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.